Jinhe Biotechnology Ownership

Jinhe Biotechnology Co has a total of 771.69 Million outstanding shares. Jinhe Biotechnology secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Jinhe Biotechnology in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Jinhe Biotechnology, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. As of November 29, 2024, Dividends Paid is expected to decline to about 90.5 M. The current year's Net Income Applicable To Common Shares is expected to grow to about 112.1 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 767.2 M. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jinhe Biotechnology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.